Información de Dexcom Inc, dividendo de Dexcom Inc, actividades de los accionistas y más

Más Datos de Dexcom Inc Compañía

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Información de Dexcom Inc



Símbolo de cotizaciónDXCM

Nombre de la empresaDexcom Inc

Fecha de salida a bolsaApr 14, 2005

Director ejecutivoMr. Jacob Steven (Jake) Leach

Número de empleados10300

Tipo de seguridadOrdinary Share

Fin del año fiscalApr 14

Dirección6340 Sequence Drive

CiudadSAN DIEGO

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal92121

Teléfono18582000200

Sitio Webhttps://www.dexcom.com/

Símbolo de cotizaciónDXCM

Fecha de salida a bolsaApr 14, 2005

Director ejecutivoMr. Jacob Steven (Jake) Leach

Ejecutivos de Dexcom Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

299.71K

+5252.00%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+2758.00%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+2424.00%

Mr. Richard Alexander Collins

Independent Director

44.38K

+2442.00%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+2428.00%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

39.80K

+4471.00%

Ms. Bridgette P. Heller

Independent Director

27.03K

-1012.00%

Mr. Kyle Malady

Independent Director

22.67K

-667.00%

Ms. Rimma Driscoll

Independent Director

9.04K

+5074.00%

Ms. Renee D. Gala

Independent Director

6.88K

+1161.00%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

299.71K

+5252.00%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+2758.00%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+2424.00%

Mr. Richard Alexander Collins

Independent Director

44.38K

+2442.00%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+2428.00%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

39.80K

+4471.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Distributor

1.03B

84.84%

Direct

183.30M

15.16%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

851.90M

70.45%

Outside of United states

357.40M

29.55%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Distributor

1.03B

84.84%

Direct

183.30M

15.16%

Estadísticas de accionistas

Actualizado: sáb., 24 de ene

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

12.54%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

3.99%

Geode Capital Management, L.L.C.

2.81%

Otro

70.11%

Accionistas

Proporción

The Vanguard Group, Inc.

12.54%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

3.99%

Geode Capital Management, L.L.C.

2.81%

Otro

70.11%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

53.15%

Investment Advisor/Hedge Fund

26.54%

Hedge Fund

7.32%

Research Firm

4.05%

Pension Fund

2.18%

Bank and Trust

1.82%

Sovereign Wealth Fund

1.61%

Venture Capital

0.48%

Individual Investor

0.38%

Otro

2.48%

Participación institucional



Actualizado: lun., 8 de dic

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

2120

388.08M

103.93%

+205.32K

2025Q3

2198

388.02M

104.56%

+4.65M

2025Q2

2236

383.14M

106.39%

+1.38M

2025Q1

2227

382.03M

104.52%

-27.81M

2024Q4

2209

376.25M

104.20%

-2.27M

2024Q3

2125

380.57M

105.64%

-16.02M

2024Q2

2097

395.55M

99.88%

+7.96M

2024Q1

2075

388.09M

102.93%

-19.55M

2023Q4

2061

396.17M

102.99%

+6.26M

2023Q3

1969

388.25M

103.58%

-414.67K

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

49.27M

12.63%

+1.13M

+2.34%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

24.32M

6.24%

+77.71K

+0.32%

Sep 30, 2025

State Street Investment Management (US)

16.86M

4.32%

-2.96K

-0.02%

Sep 30, 2025

Baillie Gifford & Co.

15.88M

4.07%

-823.03K

-4.93%

Sep 30, 2025

Geode Capital Management, L.L.C.

10.96M

2.81%

+197.42K

+1.83%

Sep 30, 2025

Invesco Capital Management (QQQ Trust)

8.75M

2.24%

+531.05K

+6.46%

Dec 31, 2025

Citadel Advisors LLC

6.78M

1.74%

+5.41M

+395.24%

Sep 30, 2025

Nuveen LLC

6.15M

1.58%

-1.15M

-15.70%

Sep 30, 2025

Jennison Associates LLC

10.09M

2.59%

-1.43M

-12.39%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

5.19M

1.33%

+237.59K

+4.79%

Jun 30, 2025

ETFs relacionados



Actualizado: mar., 2 de dic

Nombre

Proporción

Global X Internet of Things ETF

3.86%

iShares U.S. Medical Devices ETF

2.71%

Motley Fool Global Opportunities ETF

1.9%

First Trust Growth Strength ETF

1.74%

Putnam Sustainable Future ETF

1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

1.51%

Invesco S&P 500 Equal Weight Health Care ETF

1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

0.83%

iShares Russell Mid-Cap Growth ETF

0.7%

Global X Internet of Things ETF

Proporción3.86%

iShares U.S. Medical Devices ETF

Proporción2.71%

Motley Fool Global Opportunities ETF

Proporción1.9%

First Trust Growth Strength ETF

Proporción1.74%

Putnam Sustainable Future ETF

Proporción1.61%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

Proporción1.51%

Invesco S&P 500 Equal Weight Health Care ETF

Proporción1.25%

Direxion NASDAQ-100 Equal Weighted Index Shares

Proporción0.83%

First Trust NASDAQ 100 Equal Weighted Index Fund

Proporción0.83%

iShares Russell Mid-Cap Growth ETF

Proporción0.7%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Mar 28, 2022

Split

1→4

Fecha

Fecha ex-dividendo

Tipo

Relación

Mar 28, 2022

Split

1→4